Shareholders Equity: The sum of preferred and common equity items.
Radiopharm Theranostics Limited - Sponsored ADR (RADX) had Shareholders Equity of $27.76M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$25.81M |
|
-- |
|
$30.16M |
|
$56.01M |
|
$9.67M |
|
-- |
|
$18.57M |
|
$28.24M |
|
$27.76M |
|
$-2.40M |
|
|
Shareholders Equity |
$27.76M |
-- |
|
| Cash Flow Statement Financials | |
$-23.73M |
|
$1.15M |
|
$29.42M |
|
$12.03M |
|
$18.86M |
|
$6.83M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|